Author information:
(1)Diabetic Complications Division, Juvenile Diabetes Research Foundation 
Danielle Alberti Memorial Centre for Diabetic Complications, Baker IDI Heart & 
Diabetes Institute, Melbourne, Victoria, Australia; Department of Medicine, 
Monash University, Melbourne, Victoria, Australia;
(2)Diabetic Complications Division, Juvenile Diabetes Research Foundation 
Danielle Alberti Memorial Centre for Diabetic Complications, Baker IDI Heart & 
Diabetes Institute, Melbourne, Victoria, Australia;
(3)Human Epigenetics Laboratory, Baker IDI Heart & Diabetes Institute, 
Melbourne, Victoria, Australia;
(4)Diabetic Complications Division, Juvenile Diabetes Research Foundation 
Danielle Alberti Memorial Centre for Diabetic Complications, Baker IDI Heart & 
Diabetes Institute, Melbourne, Victoria, Australia; Department of Nephrology and 
Hypertension, Kawasaki Medical School, Kurashiki, Japan;
(5)Department of Pharmacology, Cardiovascular Research Institute Maastricht, 
Faculty of Medicine, Health & Life Science, Maastricht University, Maastricht, 
The Netherlands;
(6)Genkyotex SA, Geneva, Switzerland;
(7)Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and Institute of 
Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United 
Kingdom.
(8)Diabetic Complications Division, Juvenile Diabetes Research Foundation 
Danielle Alberti Memorial Centre for Diabetic Complications, Baker IDI Heart & 
Diabetes Institute, Melbourne, Victoria, Australia; Department of Medicine, 
Monash University, Melbourne, Victoria, Australia; 
karin.jandeleit-dahm@bakeridi.edu.au.